Select a State

Global health R&D delivers for Florida

US government investment in global health R&D has delivered

$94.1 million
to Florida research institutions
1,500+ new jobs
for Florida

Neglected diseases in Florida

Chikungunya cases
572
Dengue cases
779
HIV diagnoses
43,431
Malaria cases
604
Tuberculosis cases
6,531
West Nile cases
160
Zika cases
1,216
--

Florida's top USG-funded global health R&D institutions

University of Miami (including the Miller School of Medicine)
$22.5 million
University of South Florida
$15.6 million
University of Central Florida
$15.4 million
University of Florida
$12.4 million
Florida State University
$9.7 million
Vaccine and Gene Therapy Institute of Florida
$5.2 million
Torrey Pines Institute for Molecular Studies
$4.0 million
Florida International University
$4.0 million
Sanford-Burnham Medical Research Institute
$2.7 million
Florida Atlantic University
$1.1 million
Foundation for Applied Molecular Evolution
$1.1 million
Moffitt Cancer Center
$469 thousand

Florida industry in global health R&D

Alere
Location(s):
Orlando
Amgen
Location(s):
Tampa
Beckman Coulter
Location(s):
Miami
Bristol-Myers Squibb
Location(s):
Tampa
Celgene
Location(s):
Destin
Cipla
Location(s):
Sunrise
Claro Scientific
Location(s):
St. Petersburg
Gilead
Location(s):
Miami
Novartis
Location(s):
Miami, Plantation
Opko
Location(s):
Miami
Sanofi
Location(s):
Orlando
Vax Design
Location(s):
Orlando

Florida's top areas of global health R&D by USG funding

34.5%
HIV/AIDS
19.9%
Malaria
16.9%
Tuberculosis
8.3%
Diarrheal diseases
11.5%
Neglected tropical diseases
Dengue
Helminths
Kinetoplastids
8.9%
Other
Bacteria pneumonia & meningitis
Non-allocable
Salmonella infections

Global health R&D at work in Florida

University of Florida scientists are studying how Florida mosquito species spread chikungunya virus. The virus, which occurs mostly in Africa, Asia, and India, arrived in the Caribbean several years ago; since then, more than 3,800 cases have been diagnosed in Florida. The virus causes fever, headaches, muscle and joint pain, and, in some cases, chronic rheumatoid arthritis. The study will help scientists model chikungunya transmission to better control outbreaks.

Footnotes